Quantitative Systematic Strategies LLC Karyopharm Therapeutics Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$9.85 - $17.69 $108,093 - $194,130	-10,974 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$14.15 - $17.19 $89,527 - $108,761	-6,327 Reduced 36.57%	10,974 $170,000
Q3 2020 Nov 09, 2020	BUY	$14.14 - $19.71 $244,636 - $341,002	17,301 New	17,301 $253,000
Q1 2020 May 06, 2020	SELL	$14.38 - $27.72 $638,687 - $1.23 Million	-44,415 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$9.23 - $19.67 $160,740 - $342,553	17,415 Added 64.5%	44,415 $851,000
Q3 2019 Nov 07, 2019	BUY	$5.66 - $11.85 $152,820 - $319,950	27,000 New	27,000 $260,000
Q1 2019 Apr 15, 2019	SELL	$4.12 - $10.25 $44,413 - $110,495	-10,780 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$8.2 - $16.95 $88,395 - $182,721	10,780 New	10,780 $101,000

120

64.9M

500K

99K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $71M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.